Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Share Capital (Tables)

v3.24.2.u1
Share Capital (Tables)
 6 Months Ended
Jun. 30, 2024
Share Capital (Tables) [Line Items]  
Schedule of Options Granted In the six months ended June 30, 2024 and 2023, the Company granted options as follows:
    Six months ended June 30, 2024
    Number of options granted     Exercise
price
range		     Vesting
period		   Expiration
Employees     41,500     $ 5.26-5.76     4 years   10 years
Consultant     5,000     $ 5.26     4 years   10 years
    Six months ended June 30, 2023
    Number of options granted     Exercise
price
range		     Vesting
period
range		   Expiration
Employees     104,500     $ 7.5     4 years   10 years
Schedule of Fair Value of Options Granted The fair value of options granted on the date of grant was computed using the Black-Scholes model. The underlying data used for computing the fair value of the options are as follows:
    Six months ended
June 30		  
    2024     2023  
Value of ordinary share   $ 5.13-5.46     $ 7.5  
Dividend yield     0 %     0 %
Expected volatility     70.91-70.97 %     74.1 %
Risk-free interest rate     4.35-4.46 %     0.36 %
Expected term     6.11 years       6.11 years  

 
Schedule of Restricted Stock Units In the six months ended June 30, 2024, the Company granted restricted share units, or RSU, as follows:
    Six months ended
June 30, 2024		  
    Number of RSU granted     Weighted Average Grant Date Fair Value  
Employees     261,000     $ 5.13  
Schedule of Share-Based Compensation The following table illustrates the effect of share-based compensation on the statements of operations:
    Six months ended
June 30		     Three months ended
June 30		  
    2024     2023     2024     2023  
Cost of revenue   $
-
     $ 19     $ -     $ 11  
Research and development     410       307       278       121  
General, administrative and marketing     370       526       212       206  
    $ 780     $ 852     $ 490     $ 338  
Employees and Directors [Member]  
Share Capital (Tables) [Line Items]  
Schedule of Options Granted The following table summarizes the activity in options granted to employees and directors  for the six months period ended June 30, 2024:
    Number of
options		     Weighted
average
exercise
price		     Weighted average remaining contractual term
(in years)		     Aggregate intrinsic value  
Options outstanding at the beginning of the period     1,745,880     $ 5.8       5.91     $ 1,165  
Granted     41,500       5.34                  
Exercised     (1,840 )     5.07                  
Expired     (9,565 )     8.33                  
Forfeited     (11,970 )     5.77                  
Options outstanding at the end of the period     1,764,005     $ 5.78       5.53     $ 335  
Options exercisable at the end of the period     1,296,239     $ 5.59       4.53     $ 335  

 

The following table summarizes the activity in options granted to consultants for the six months period ended June 30, 2024:
    Number of
options		     Weighted
average
exercise
price		     Weighted average remaining contractual term
(in years)		     Aggregate intrinsic value  
Options outstanding at the beginning of the period     11,666     $ 16.78       1.36     $      2  
Granted     5,000       5.26                  
Options outstanding at the end of the period     16,666     $ 12.91       3.53     $
-
  
Options exercisable at the end of the period     6,329     $ 9.65       0.85     $
-
  
The following table summarizes the activity in RSU granted to employees under the 2024 Plan for the six months period ended June 30, 2024:
    Number of
options		     Weighted
Average
Grant Date
Fair
Value		  
Unvested at the beginning of the period     0     $ 0  
Granted     261,000       5.13  
Unvested at the end of the period     261,000     $ 5.13